Latest filing published 14 Sept 2023 for Swedish Orphan Biovitrum AB (publ), €7,658.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Staffan Schüberg: trading record in brief
Staffan Schüberg discloses dealings in Swedish Orphan Biovitrum AB (publ) to Finansinspektionen. In total, 2 filings cover trades dated from 12 September 2023 to 14 September 2023.
Every open-market trade on record is a purchase: 1 purchase worth €37k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 14 September 2023, reports a transaction of €7,658 in Swedish Orphan Biovitrum AB (publ). The clock since the last published purchase (14 September 2023) now reads 1,152 days. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Staffan Schüberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 642 shares@ SEK 142.0017.2% of flowBTA (betald tecknad aktie)ISIN SE0020846293FI:csv-2dba365c244c89849261
- 2,000 shares@ SEK 219.7482.8% of flowAktieISIN SE0000872095FI:csv-89732a0b96ca0f355335Canonical exit: 11 Dec 2023 (T+90)
2 of 2 declarations